Previous 10 | Next 10 |
Safety and Immunogenicity Examined in Phase 1 Trial of GPS plus Anti–PD-1 Nivolumab in Patients with WT1-Expressing Relapsed Ovarian Cancer in the Post-Salvage Setting Immune Response Translated into Clear Clinical Benefit with 70% One-Year Progression-Free Survival Demonstrated ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/T. Schneider ShiftPixy (NASDAQ: PIXY ) stock is on the move Friday after the company announced plans to use ChatGPT for recruiting and hiring . ShiftPixy notes that this will have it inte...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: vaalaa / Shutterstock Boeing (NYSE: BA ) stock is a hot topic among traders on Friday after the company halted deliveries of its 787 Dreamliners . This halt was put in place as the company investigates an...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com Nektar Therapeutics (NASDAQ: NKTR ) stock is taking a beating on Friday following the release of Phase 2 clinical trial data . This Phase 2 study had Nektar Therapeutics te...
Sellas Life Sciences Group ( NASDAQ: SLS ) shares fell 44% Friday morning after the biopharmaceutical company priced its $20M securities offering. The offering comprises 7,220,217 shares of common stock and accompanying warrants to purchase up to 7,220,217 shares of common sto...
NEW YORK, Feb. 24, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announce...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: aslysun / Shutterstock.com SELLAS Life Sciences (NASDAQ: SLS ) stock is falling on Friday after the late-stage clinical biopharmaceutical company announced a proposed public offering . According to a pres...
SELLAS Life Sciences ( NASDAQ: SLS ) said Thursday it has commenced an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock. Shares -32.3% at $2.50 after hours. All of the securities in the offering will be sold by SELL...
VANCOUVER, British Columbia, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; OTCQB: SLSSF) (“Solaris” or “the Company”) is pleased to report updated geochemical sampling and assay results from follow-up holes at Warintza West within its Warintza...
VANCOUVER, British Columbia, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Solaris Resources Inc . (TSX: SLS; OTCQB: SLSSF) (“Solaris” or “the Company”) is pleased to report results from metallurgical test work on its Warintza Project (“Warintza” or “the P...
News, Short Squeeze, Breakout and More Instantly...
SELLAS Life Sciences Group Inc. Company Name:
SLS Stock Symbol:
NASDAQ Market:
SELLAS Life Sciences Group Inc. Website:
2024-07-19 10:10:00 ET July 19, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech, Cleantech Sectors. The newest biotech companies are involved in blood disorder treat...
- Acute Myeloid Leukemia (AML) is the Second Most Common Hematological Malignancy in Children Often Associated with Poorer Prognosis Compared to Other Pediatric Cancers – - This Recognition Marks SELLAS’ Second RPDD Following the Designation for ALL Received Last Month - -...
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today ...